Glucagon-like peptide-1 and its class BG proteincoupled receptors: a long March to therapeutic successes
In the treatment of obesity, there was basically nothing decent beforehand
Weight loss achieved through semaglutide use may indirectly benefit certain digestive conditions associated with obesity, such as gastroesophageal reflux disease (GERD) or metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), but this represents a secondary effect rather than direct gut healing
Learn More Wellness Injections B12, MIC, fat burner shots, NAD+, and wellness injection support
GHK-Cu in Vietnam Commonly paired for collagen, skin, and wound-healing research
Author contributions AI: Supervision, Formal analysis, Writing review & editing, Validation